t is very important to assess and predict risk in the cardiovascular system before noncardiac surgery. A number of cardiac indexes for predicting risk have been developed, and it is recommended to evaluate patients using these indexes and to institute preoperative medical treatment or coronary revascularization based on the results. [1] [2] [3] [4] These clinical scoring systems, although simple to use, are somewhat inconvenient and have limitations in their predictive value, 2 whereas other cardiac investigations such as exercise or pharmacologic stress imaging are sensitive, but limited in practice by time and resources. 5 Recently brain natriuretic peptide (BNP) was spotlighted as a predictor for diagnosing and predicting the prognosis of various heart diseases. BNP is a cardiac hormone that is synthesized by ventricular myocytes in response to ventricuCirculation Journal Vol.72, February 2008 lar dysfunction and wall stress. 6 Recent studies have demonstrated that elevated serum BNP levels predict first cardiovascular event and death in the general population. 7, 8 In addition, it has been reported that BNP measured before cardiac surgery can be used as a predictor of postoperative cardiac complications. 9 Thus we assumed that the preoperative N-terminal (NT)-proBNP concentration would also predict postoperative cardiovascular complications and prognosis in noncardiac and nonvascular surgery, so in the present study we compared the revised cardiac index, the preoperative BNP concentration and postoperative complications in elderly patients aged over 60 years in whom the risk of postoperative complications was relatively high.
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Methods

Study Population
We prospectively analyzed patients aged over 60 years who had been admitted to Wonkwang University Hospital for noncardiac and nonvascular operation under general anesthesia during the period from January to December 2006. We excluded patients who had an emergency operation, those who had left ventricular (LV) dysfunction (ejection fraction <50%), those who were receiving hemodialysis or peritoneal dialysis for renal failure, and those who had a severe degree of valvular heart disease. All patients gave informed consent according to a protocol approved by the hospital's medical ethics committee. In total, 279 patients (age 68±8 years, males 51.6%) were enrolled.
Perioperative Cardiac Risk Assessment
Basic demographic data and factors relating to the cardiac risk of surgery were gathered prospectively for each patient. The risk of cardiac events was calculated using the revised cardiac risk index, 2 which is a standardized, validated clinical scoring system, based on the presence of 6 clinical variables: high-risk surgery, history of ischemic heart disease, congestive heart failure, cerebrovascular disease, insulin therapy for diabetes mellitus, preoperative serum creatinine >2 mg/dl. The type of surgery was classified according to the guideline of the American College of Cardiology and the American Heart Association (ACC/AHA): high risk, intermediate risk and low risk. 1 For all the patients, venous blood was collected at the time of transthoracic echocardiography and the concentration of NT-proBNP was measured immediately using an immunoassay kit (Elecsys 2010, Roche Diagnostics, Germany). The mean time of venous sampling before surgery was 5±3 days.
Echocardiographic images were acquired in the standard parasternal and apical views by experienced sonographers. The left atrial (LA) diameter was measured by 2D-guided M-mode echocardiography in the parasternal short-axis view at the base of the heart, according to the American Society of Echocardiography recommendation. 10 LA size was indexed to body surface area for analysis. LA size index >24 mm/m 2 was considered abnormal. LV wall thickness was measured as the interventricular septal and posterior wall thickness at end-diastole. LV hypertrophy was defined as a LV mass index ≥125 g/m 2 in men and ≥110 g/m 2 in women. 11 LV diastolic filling pattern was assessed by placing the pulse-wave Doppler sample volume at the tips of the mitral valve leaflet and to discriminate from a pseudonormal filling pattern, we assessed the tissue Doppler velocity of the mitral annulus.
Study Endpoint
The patients were observed for 30 days after surgery. The primary endpoint was the occurrence of an adverse cardiovascular event defined as cardiac death, ischemic heart disease, acute pulmonary edema or nonfatal stroke. Twelve-lead electrocardiography (ECG), and measurement of the concentrations of serum creatine kinase MB fraction and troponin T, were performed immediately after surgery and 1 day after surgery. Additional ECG, chest X-ray, brain computed tomography or magnetic resonance imaging, or cardiac enzymes measurement was performed if the patients showed signs or symptoms of cardiovascular complications.
Statistical Analysis
Statistical analysis was performed using SPSS 11.5 for Window (SPSS Inc, Chicago, IL, USA). Univariate analyses between patients with perioperative cardiovascular complications and those without were conducted using the chisquare test and independent t-test. Receiver-operating characteristic (ROC) curve analysis was performed to calculate the sensitivity and specificity, and the area under the curve to select a cut-off value for predicting perioperative cardiovascular events. Multivariate analysis was done to determine the factors related to perioperative cardiovascular complications. The variables were selected according to significant univariate analysis, and odds ratios (OR) are given with 95% confidence intervals (CI). For continuous variables, the median value was used as a cut-off point for determination of perioperative adverse events. Statistical significance was set at p<0.05. The Kaplan-Meier method and log-rank test were used for cumulative event-free survival analysis.
Results
Baseline Characteristics
The mean age of the subjects was 68±8 years, and men comprised 51.6% of the group. Of the patients, 1 underwent thoracic surgery, 6 had intraperitoneal surgery, 15 had head and neck surgery, 60 had retroperitoneal surgery, 72 had orthopedic surgery, 36 had endoscopic surgery, 56 had transurethral resection of prostate, and 33 had other general surgery. Cardiovascular complications occurred in 25 patients (9.0%): 1 case (0.4%) of cardiac death (fetal myocardial infarction (MI)), 4 of nonfatal MI (1.4%), 17 of acute pulmonary edema (6.1%) and 3 of acute ischemic stroke (1.1%). We compared these with the patients without complications.
Age (73.1±9.6 vs 67.5±8.2 years, p=0.001), the incidence of prior ischemic heart disease (20.0 vs 5.5%, p=0.019), and prior congestive heart failure (20.0 vs 3.1%, p=0.003) were significantly higher in patients with perioperative cardiovascular complications than in those without (Table 1 ). In addition, ejection fraction (59.5±8.7 vs 63.5±6.8%, p=0.007) and hemoglobin (10.9±1.6 vs 12.3±1.6 g/dl, p<0.001) were significantly lower and the NT-proBNP level (1,127.5± 1,394.1 vs 178.1±453.6 pg/ml, p=0.002) was significantly higher in the group with complications than in that without. The incidence of LA enlargement was higher in patients with complications than in those without (24.0 vs 10.2%, p= 0.039). The revised cardiac index was significantly higher, and high-risk surgery was more frequently performed in the group with complications. Operation time was also longer (196.8±110.3 vs 105.3±71.0 min, p<0.001), and perioperative transfusion was performed more frequently (16.0% vs 4.7%, p=0.044) in the patient group with complications.
Relationship Between Cardiac Events and NT-ProBNP Level
Using ROC curve analysis to predict perioperative cardiovascular events, a cut-off value of 201 pg/ml was identified as the optimal predictor of perioperative complications, showing a sensitivity of 80.0% and specificity of 81.1% (Fig 1) . Area under the curve was 0.855 (p<0.001). Based on 201pg/ml, we divided the patients into 2 groups and evaluated their event-free survival using the Kaplan-Meier method (Fig 2) . Complications occurred usually within 1 week (16 patients, 68.0%). Patients with NT-proBNP ≤201 pg/ml showed a lower incidence of cardiovascular complications and longer mean event-free time than those with higher NT-proBNP (30±0 vs 24±1 days, p<0.001).
Independent predictors for perioperative cardiovascular events identified through multivariate analysis were NTproBNP >201 pg/ml (OR 7.6, 95% CI 2.2-26.6, p=0.003) and revised cardiac index ≥2 (OR 6.3, 95% CI 1.7-23.8, p= 0.007) ( 
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Discussion
The present study showed that elevated levels of NTproBNP are significantly associated with an increased risk for perioperative cardiovascular complication in elderly patients undergoing noncardiac and nonvascular surgery. Using the cut-off value of 201 pg/ml NT-proBNP is a simple, practical method of predicting perioperative adverse cardiovascular events.
It is very important to determine the risk of cardiac complications before noncardiac surgery, particularly in elderly patients, who are likely to already have heart disease and whose response to transfusion or fluid therapy is thus weakened. Regardless of whether they have cardiovascular disease, elderly patients aged over 60 years have a death rate of 2.9-5.8% because of postoperative complications and the rate rises up to 8% in those aged over 80 years. 12 Accordingly, it is as essential to determine preoperative risk in the elderly, as it is in other age groups. To date, several indexes have been developed, including the ACC/AHA guideline, the modified cardiac index, the revised cardiac index and the Goldman index (original cardiac index); [1] [2] [3] [4] however, each of these has a limitation in prognostic value, and some of them are quite complex in application. 2 Thus, we became interested in BNP, believing that it could be a more convenient and easier marker.
BNP was first discovered in the porcine brain, but it is actually secreted by both atrial and ventricular myocytes. 13 ProBNP is cleaved (probably at the time of secretion from the cardiac myocyte) into BNP and NT-proBNP, the latter being endocrinologically inactive. In health, BNP is only detectable at very low concentrations in the venous blood (typically 5 picomolar), with an approximate plasma halflife of just over 20 min. Unlike BNP, NT-proBNP has a higher plasma concentration than BNP and less response to exercise, suggesting that its half-life is longer than that of BNP. 13 The plasma concentration of NT-proBNP does not appear to be affected by inhibition of neutral endopeptidase. Both BNP and NT-proBNP are widely used in the diagnosis and prognosis of congestive heart failure and ischemic heart disease, [14] [15] [16] [17] [18] [19] [20] and can be measured easily at low cost and in a short time.
Recently BNP was reported as an indicator for predicting complications in open-heart surgery or major vessel surgery. Hutfless et al 9 reported that preoperative BNP over >385 pg/ml predicted postoperative complications and oneyear mortality in 98 patients who underwent open heart surgery, 9 and Feringa et al reported that preoperative NTproBNP ≥533 pg/ml was a predictor of cardiac death and nonfatal MI during 30-day follow-up in 170 patients who had undergone major vascular surgery. 21 In our study, the NT-proBNP level was relatively lower than that in the other research, probably because the all the present patients had an ejection fraction >50% and underwent relatively low-risk surgery.
The reasons that BNP can predict the postoperative complications of noncardiac surgery are presumed to be as follows. First, BNP is related to diastolic dysfunction of the heart. 22, 23 In the present study, the occurrence of pulmonary edema was included in the endpoint. As diastolic dysfunction is common in elderly patients, pulmonary edema often occurs after fluid therapy or transfusion. Accordingly, it is likely that the BNP level will reflect diastolic dysfunction even when systolic function is normal. Second, BNP is related to the atrium. Reports have shown that elevated BNP occurs patients with lone atrial fibrillation, 24, 25 which suggests that the atrium may be also synthesizing and secreting BNP. In our study, although all patients have normal LV function, those with perioperative complications had a large LA and high BNP level. Therefore, BNP may represent the subject's atrial status and be secreted by the atrium itself. Third, BNP can increase not only in congestive heart failure but also in other systemic conditions, such as chronic obstructive pulmonary disease, diabetes, renal failure, liver cirrhosis etc. 13 These diseases can be risk factors for postoperative complications and some of them are actually a component of several cardiac indexes.
Study Limitations
The present study was limited to patients with preserved LV systolic function, and there were relatively few patients. Further, the beneficial effects of BNP and the cardiac index on the incidence of postoperative cardiovascular events were not directly compared. Accordingly, prospective multicenter studies with a large number of patients in various settings are required.
In conclusion, the NT-proBNP level, based on a cut-off value of 201 pg/ml, is an independent predictor for perioperative cardiovascular complications in elderly patients. However, further research with a large number of patients, and including various types of high risk surgeries, is necessary.
